Over 26 weeks, including a dose-escalation period of up to 6 weeks, researchers observed mean percentage weight reductions of 6.0% to 10.8% across the cagrilintide dose groups compared to just 3.0% with placebo
Type of study: Number of citations: 1 Year: 2025 Authors: Kehan Chen, Hui Yang, Guo Xu, Yunhan Hu, Xue Tian, Song Qin, Tianyue Jiang Journal: RSC medicinal chemistry Journal ranking: Q1 Key takeaways: The Cur-CNEs/Gel, an oligopeptide hydrogel encapsulating curcumin-loaded nanoemulsions, effectively enhances skin penetration and alleviates psoriasis symptoms in mice
No fillers
The not-so-sterile womb: evidence that the human fetus is exposed to bacteria prior to birth
These are the questions that make the comparison meaningful, with our answers next to them so you can hold us to the same standard you would hold anyone else